澳優(01717.HK):不知悉監管體制或商業生態出現或導致業務前景產生重大不利影響變動
澳優(01717.HK)公佈聲明以迴應近期互聯網上流傳有關嬰幼兒配方奶粉行業監管體制可能出現轉變之評論,指注意到公司股份自今年7月初起之成交價下跌及成交量上升。經公司就有關情況作出屬合理之查詢後,董事會確認並不知悉任何導致股價及成交量出現有關波動之原因;任何必須公佈以避免公司證券出現虛假市場之資料;或任何根據香港法例第571章證券及期貨條例第XIVA部須予披露之內幕消息。目前,董事會並不知悉監管體制或商業生態出現任何可能導致公司業務前景產生重大不利影響之變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.